Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)


Next week, the Multidisciplinary Association for Psychedelic Studies (MAPS) will bring a host of psychedelic scientists and visionary artists together in San Jose, California for the largest conference of its kind in the U.S. in 17 years.





Recent comments
12 hours 55 min ago
4 weeks 18 hours ago
4 weeks 6 days ago
14 weeks 6 days ago
18 weeks 6 days ago
19 weeks 6 days ago
20 weeks 2 hours ago
41 weeks 14 hours ago
45 weeks 1 day ago
46 weeks 5 days ago